ProAxsis
London, GB · 1 known investors
Find your way into ProAxsis
ProAxsis provides biomarker analysis services and research assays for respiratory disease drug development, serving pharmaceutical, biotechnology, and academic research organizations.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- PROAXSIS LTD
- Company number
- NI619901
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 16 Aug 2013
- Registered office
- Building 75, Randox Science Park, 30 Randalstown Road, Antrim, BT41 4FL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.86900 — Other human health activities
- Previous names
- PROAX-SIS LTD (2013–2014)
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 12 Aug 2026 · next due 26 Aug 2027
Current officers · 2
- Steven Hla Myint — director, appointed 10 Nov 2023
- Emv Director Services Limited — corporate director, appointed 2 Mar 2023
Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does ProAxsis do?
- ProAxsis provides biomarker analysis services and research assays for respiratory disease drug development, serving pharmaceutical, biotechnology, and academic research organizations.
- Who are ProAxsis's investors?
- ProAxsis's investors include EMV Capital.
- Where is ProAxsis headquartered?
- ProAxsis is headquartered in London, GB.